ACM Research, Inc. (ACMR): what the price assumes

In the published model solve dated 2026-Q2, anchored at $74.44, ACM Research, Inc. (ACMR) is priced for today's economics sustained for ~17.2 years. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-25.

Generated: 2026-09-07 · Exported: 2026-09-09 · Source: https://boothcheck.com/report/ACMR

Headline

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

The operating-margin figure is value-band context at year 5: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 14.1% cost of capital; growth searched up to the 25% self-funding ceiling.

How unusual the bet is: elevated (limited comparison data)

Valuation X-Ray

Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Families that justify the price: Growth Families that call it expensive: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.7%); the inversion above states its own rate.

Per-Model Detail (n=14)

Economic-Unit Decomposition (Sum Of The Parts)

Only one reportable economic unit is present in the current topology source. Consolidated operating lenses remain available, but there is no multi-unit decomposition.

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

Bullet Takeaways

• Wet cleaning is still the core of this company, with single wafer cleaning, Tahoe and semi-critical cleaning equipment producing "$626.0 million, or 69.5% of total revenue in 2025", while electroplating, furnace and other technologies now supply another fifth of the top line.
• The equity base is expanding faster than the profit base: the share count has risen about 4.4% a year over the four years to March 2026, and the 2025 balance-sheet build came from raising money rather than from operations.
• Second quarter results arrive before the U.S. market opens on August 7, 2026, and the shipment figure relative to revenue is the line that says whether the full-year range is safe.

Bull Case

Almost every way of valuing this company from its past lands far below $84.31, and exactly one way of valuing it from its future lands right at it. That is not a contradiction. It is a description of what is being bought. The lenses built on book value and the returns earned on it read the price as close to eight times what they support. Capitalized current earning power reads it as roughly five times. Peer ratios read it as about two and a half times. Only the method that carries revenue forward at the pace the business has been growing, and applies today's price-to-sales ratio at the far end, reaches the price at all. Anyone buying here is making a claim about the next decade of growth, not about the last twelve months of profit.

The claim is not absurd, because equipment businesses compound in a specific way. Lam Research, the largest company in this cohort, describes the mechanic in its own annual filing: "We believe that once a semiconductor manufacturer selects a particular supplier's processing equipment, the manufacturer generally relies upon that equipment for that specific production line". Qualification is slow, expensive and rarely revisited. A tool that wins a production line tends to keep winning it, and then sells consumables, spares and service against it for years. That is why a supplier with a small installed base and a growing one can look expensive on trailing numbers and still be early.

The mix is doing something interesting. Cleaning revenue moved from "$403.9 million, or 72.4% of total revenue in 2023" to "$578.9 million, or 74.0% of total revenue in 2024" and then to $626.0 million in 2025, which is slower growth than the company's overall pace. The difference came from the newer lines: electroplating, furnace and other technologies reached "$199.6 million, or 22.1% of total revenue". A single-product supplier is a customer's convenience. A supplier with four or five qualified tool types starts to be part of the fab's plan, and that shift is visible in the revenue split rather than in a management slide.

Demand has a stated source, and it is a multi-year one. The company attributes its growth to "a longer-term commitment by our mainland China-based customers to increase production capacity to achieve a greater share of the global semiconductor market". Domestic capacity building of that kind is measured in fab construction cycles, not quarters, and it comes with a strategic preference for domestic suppliers that no Western competitor can neutralise by cutting price. On pricing the company is explicit about its intent: "We seek to maintain our gross margin by continuing to develop proprietary technologies that avoid pricing pressure for our wet cleaning equipment."

Finally, the financial position gives the bet time to work. The balance sheet carries $578.8 million in net cash, and operating profit covers the interest bill about 17.3 times. Management's forecasting record is better than the sector norm: since 2018 it has raised its outlook on eight occasions against a single cut, and of the four revenue guides that could be scored against reported results, it delivered on all four. A growth story that keeps its own promises is a materially different proposition from one that keeps revising them.

Bear Case

The cash on this balance sheet did not come from the business. The 10-K is precise about where it came from: total cash, equivalents, restricted cash and time deposits stood at $1,132.6 million at the end of 2025 against $441.9 million a year earlier, and "The $690.7 million increase was primarily driven by $742.5 million net cash provided by financing activities". Put alongside a share count rising about 4.4% a year over the four years to March 2026, the picture is a company reporting profit while funding its expansion in the capital markets. Existing holders paid for that growth in ownership.

The ownership structure adds a second layer of the same problem. The operating business in mainland China is separately listed, and the parent's disclosure does not soften it: "As the result of actions taken in connection with the STAR Listing and the STAR IPO, ACM Shanghai is no longer a wholly owned subsidiary of ACM Research, and the interests of ACM Shanghai may diverge from the interests of ACM Research and its other subsidiaries". It goes further and names the mechanism: "In the future, ACM Shanghai may issue options, restricted shares and other forms of share-based compensation to its directors, officers and employees, which could dilute ACM Research's ownership in ACM Shanghai." A holder of the U.S. listing can therefore be diluted at the parent and again at the entity that actually owns the factories and the customer relationships.

The money is also not entirely portable. Under the filing's description of mainland rules, "The mainland China subsidiaries are prohibited from distributing dividends unless any losses from prior years have been offset", and "statutory surplus reserves must be maintained at a minimum of 25% of share capital". The net cash is real and it is a genuine buffer against a downturn. Whether it is available to a New York shareholder in any form other than book value is a different question, and the answer is not simply yes.

Against that, look at what the price asks. The market pays about 43 times trailing operating profit and, on the arithmetic that reconciles the two, requires profit to compound at the fastest pace the business can fund from its own resources and to sustain that for about 20 years. Only about 14% of comparable fast-growers have held such a pace even for a decade. The multiple itself sits at the very top of the semiconductor equipment cohort, well past the upper quartile. Nothing in the trailing numbers is broken; the issue is that the price has already spent the next two decades of success. Shorten the horizon by a few years and the multiple, not the business, is what corrects.

The competitive geometry is unfavourable in a way management acknowledges. Rivals "supply equipment for a larger number of process steps than we do to a broader customer base in an industry with a limited number of customers", and the customer base itself is thin: "There are also a limited number of potential customers for our products." Among those peers Lam Research earns a 34.3% operating margin on $21.7 billion of revenue, roughly two and a half times ACM Research's 13.8% on a revenue base a small fraction of the size. Trade policy sits on top of all of it, and the filing flags a specific edge case: "The new restrictions may also limit the ability of ACM Shanghai and ACM Korea personnel to provide services to U.S. customers". A supplier whose growth depends on one national capacity build, whose engineers face restrictions on serving customers elsewhere, and whose stock carries the cohort's highest multiple has very little margin for a policy change.

Valuation

Start with the arithmetic the price contains. At $84.31, observed on July 25, 2026, the market pays about 43 times trailing operating profit. To reconcile that with a cost of capital near fourteen percent, profit has to compound at the ceiling the business can fund from its own cash generation, and it has to keep doing so for about 20 years. The near-term pace is not the stretch; ACM Research has grown that fast recently. The stretch is the persistence, and the reference points are unkind: only around 14% of comparable fast-growers have held such a pace for as long as a decade, and this multiple sits at the very top of the semiconductor equipment group rather than inside it.

The reason the conventional methods land so far below is arithmetic rather than skepticism. Trailing operating profit is $122.6 million, a small base for a company valued at nearly six billion dollars, and profitability of 13.8% at the operating line is roughly what a mid-sized equipment maker earns. Anything that capitalizes today's profit, or values the equity against book value and the returns on it, is measuring a company that has not yet arrived. That is why those lenses read the price as several times what they support. They are not wrong about the present; they simply have no instrument for the future.

One method reaches today's price, and it is worth knowing exactly what it does. It projects revenue forward at roughly the growth rate the company has been delivering, tapers that growth, and applies today's price-to-sales ratio at the end. It reaches $84.31 because it assumes the market will still pay today's sales multiple after the growth has happened. Notably, the discounted cash-flow methods produced nothing at all, because free cash flow is not currently positive: the company converts reported profit into inventory and receivables faster than into money. So the single lens that defends the price is a multiple projection, not a cash-flow test. That distinction matters more than any individual number in this section.

The cohort makes the point another way. Among the peer group, Lam Research runs a 34.3% operating margin on $21.7 billion of revenue; Axcelis, a closer comparison by size, earns 11.6% on $845 million; Veeco manages 2.9% on $655 million. ACM Research's 13.8% places it above the smaller peers and far below the leader, which is a reasonable place for a company at this stage. It is priced, however, at the top of that same group. Being mid-cohort on economics and top-of-cohort on price is the whole tension in one line.

The balance sheet is genuinely strong and it does not resolve the tension. Net cash of $578.8 million and interest cover of about 17.3 times mean insolvency is not the risk under discussion; the risks are dilution and duration. One further sensitivity is worth stating: a single extra percentage point of cost of capital cuts roughly three years off the period over which today's price can be reconciled with the business. For a stock whose price moves at twice the market's amplitude, that is not a rounding detail. It is the difference between a demanding bet and an unreachable one.

Catalysts

The most recent quarter was strong on both of the numbers this company is judged by. First quarter 2026 revenue came in at $231 million, up 34% year over year, with shipments of $241 million, up 54%. Shipments running ahead of revenue matters here because tools are recognised on acceptance, so shipment growth is the leading indicator and revenue the lagging one. Management said it expects annual shipment growth to outpace revenue growth for the full year.

Full-year 2026 revenue guidance stands at $1,080 million to $1,175 million, which management reaffirmed alongside those first quarter results. The company framed the range explicitly around trade policy, customer spending scenarios, supply chain constraints and the timing of acceptances for first tools under evaluation. That last item is the one worth tracking: a first tool sitting in a customer's fab awaiting sign-off is revenue that exists but has not yet been recognised, and its timing can move a quarter in either direction without telling you anything about demand.

The next checkpoint is dated. ACM Research releases second quarter 2026 results before the U.S. market opens on August 7, 2026, with the conference call the same morning. Three things in that release carry information: whether shipments continue to lead revenue, whether the full-year range is narrowed or moved, and whether operating profitability holds as the newer product lines take a larger share of the mix.

Peer Cohorts (Per Segment, With Filing Citations)

Semiconductor process equipment (single reportable segment) (reported)

• LRCX (LAM RESEARCH CORPORATION)
• FY2025 10-K: …into a semiconductor production line. We believe that once a semiconductor manufacturer selects a particular supplier's processing equipment, the manufacturer generally relies upon that equipment for that specific production line application for an extended period of time, especially for customers that are more…
• FY2025 10-K: …Revenue is recognized in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods or services. Inventory Valuation: Inventories are stated at the lower of cost or net realizable value using standard costs that approximate actual costs on a first-in, first-out basis.…
• ACLS (AXCELIS TECHNOLOGIES INC)
• FY2025 10-K: …a party to litigation that arises in the normal course of our business operations. ​ (c) Indemnifications ​ Our system sales agreements typically include provisions under which we agree to take certain actions, provide certain remedies and defend our customers against third-party claims of intellectual property…
• FY2025 10-K: …(including the introduction of 5G mobile networks), artificial intelligence, large language models (e.g. ChatGPT), data analytics and visualization, and the growth in the Internet of Things, and the increasing complexity of device features. These chips are used in power management, data input, such as image sensors,…
• VECO (VEECO INSTRUMENTS INC.)
• FY2025 10-K: …and measures its results in one operating segment and therefore has one reportable segment: the development, manufacture, sales, and support of semiconductor and thin film process equipment primarily sold to make electronic devices. The accounting policies of this one operating segment are the same as those described…
• FY2025 10-K: ​ ​ 630 See accompanying Notes to the Consolidated Financial Statements. ​ F-8 Table of Contents Note 1 - Significant Accounting Policies ​ (a) Description of Business ​ Veeco Instruments Inc. (together with its consolidated subsidiaries, "Veeco," or the "Company") operates in a single segment: the development,…
• ASML (ASML HOLDING NV)
• FY2025 20-F: …Scope 3 CO 2 e emissions intensity All other indirect carbon dioxide emissions that occur in an organization's value chain expressed as a percentage of revenue or gross profit. SEC The United States Securities and Exchange Commission SEMI Semiconductor Equipment and Materials International SEMI S2 SEMI S2 - Safety…
• FY2025 20-F: …manufacturing equipment and serve as a bridge to the customers who depend on them. Read more STRATEGIC REPORT CORPORATE GOVERNANCE SUSTAINABILITY FINANCIALS ASML Annual Report 2025 31 At a glance Q&A with the CEO Our business Financial p erformance Risk and security Our business strategy (continued) 2 Extend our…

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Economic-unit decomposition (SOTP): each disclosed business unit is assigned its native valuation basis before any multiple is applied. Operating units are valued on enterprise value; funded financial units are valued on their own common equity, because their borrowings fund earning assets rather than levering the parent. A company total is stated only once every material unit carries a supported value and the parent capital bridge reconciles.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.